RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$561M
AUM Growth
+$216M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1
+$12.6M
2
+$12.3M
3
+$10.2M
4
AMGN icon
Amgen
AMGN
+$9.56M
5
NKTR icon
Nektar Therapeutics
NKTR
+$8.34M

Top Sells

1
+$6.79M
2
+$5.83M
3
+$4.63M
4
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$4.37M
5
CELG
Celgene Corp
CELG
+$3.57M

Sector Composition

1 Healthcare 88.44%
2 Financials 0.78%
3 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.71M 0.46%
114,000
77
$2.64M 0.44%
20,900
+3,000
78
$2.6M 0.44%
45,000
+10,000
79
$2.4M 0.4%
+26,741
80
$2.27M 0.38%
267
-169
81
$2.12M 0.36%
60,000
+10,000
82
$1.74M 0.29%
+4,300
83
$1.51M 0.25%
227,829
84
$1.33M 0.22%
+45,388
85
$818K 0.14%
1,221
86
$733K 0.12%
133,535
87
$535K 0.09%
+14,200
88
– –
-70,000
89
– –
-22,000
90
– –
-61,000
91
– –
0
92
– –
-38,000
93
– –
-18,500
94
– –
-38,000
95
– –
-89,000
96
– –
-57,000
1 2 3
4